Masimo’s board considered other potential partners before determining Danaher was an “ideal fit,” executives at the patient ...
Danaher Corporation (NYSE:DHR) announced it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: ...
Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics ...
By Sabrina Valle and Gnaneshwar Rajan Feb 17 (Reuters) - Danaher, a $150 billion U.S. company that makes tools used in ...
Masimo Corporation (Nasdaq: MASI) ("Masimo"), a leading global medical innovator, today announced that it has entered into a ...
Danaher has struck an almost $10bn deal to buy patient monitoring company Masimo, two years after an activist investor ...
Dealbreaker on MSN
Danaher drops $10B to snatch Masimo in diagnostics push
The move reflects a broader industry shift toward consolidation and integrated care, as large healthcare companies seek scale ...
The Financial Times reports that Danaher is on the verge of acquiring Masimo in a deal worth approximately $9.9 billion.
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies used in top hospitals, announced today FDA clearance of Stork™, a revolutionary baby ...
Universal Surveillance Monitoring with Masimo SET ® Pulse Oximetry and Patient SafetyNet™ – Repeatedly Shown to Improve Patient Outcomes and Save Lives – Also Projected to Yield Significant Cost ...
After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. The medtech has tapped Katie Szyman for the role, who has been serving as the worldwide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results